Modivcare Announces Executive Leadership Transitions Amid Strategic Business Model Evolution Modivcare Inc. (Nasdaq: MODV), a leading technology-enabled healthcare services company focused on delivering supportive care solutions that address social determinants…
TAE Life Sciences and Ohio State Forge Landmark Partnership to Advance Boron-Based Precision Cancer Therapies In a significant leap forward for precision oncology, TAE Life Sciences (TLS), a pioneer in…
Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, a Moving Documentary on Dogs Leading the Fight Against Cancer The Emmy Award-winning Shelter Me series has released the official…
HAYA Therapeutics to Present Breakthroughs in RNA-Guided Regulatory Genome Platform at 2025 ASGCT Annual Meeting HAYA Therapeutics, SA, a biotechnology company at the forefront of developing precision RNA-guided therapeutics that…
Immunome Grants Equity Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) as Part of Talent Expansion Strategy Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biotechnology company pioneering innovative cancer therapies…
Astria Therapeutics Grants Stock Options to New Employees Under Nasdaq Listing Rule 5635(c)(4) Astria Therapeutics, Inc. (Nasdaq: ATXS), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for allergic and…
AN2 Therapeutics Reports Phase 3 Data from EBO-301 Trial and Details Strategic Pipeline Advancements Across Boron Chemistry Platform AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company pioneering boron-based small…
Genmab to Submit sBLA to FDA for Epcoritamab in Combination with Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma Genmab A/S (Nasdaq: GMAB) has announced its plan to submit…
InnoCare’s Next-Generation TRK Inhibitor Zurletrectinib Granted Priority Review by China’s NMPA for NTRK Fusion-Positive Tumors A prominent biopharmaceutical company dedicated to the development of innovative therapies for cancer and autoimmune…
Adicet Bio Issues Equity Awards to New Employees Pursuant to Nasdaq Inducement Rule 5635(c)(4) Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company advancing gamma delta T cell therapies for cancer,…
Global Lipid-Based Pharma Excipients Market Set to Reach $1.32 Billion by 2030, Driven by Innovation and Rising Demand for Advanced Drug Delivery Systems The newly released report, “Lipid-Based Pharma Excipients…
Landmark Study Demonstrates Significant 4-Year Survival Benefit in Heart Transplant Patients Using Paragonix SherpaPak System Paragonix Technologies, a pioneer in advanced organ transplant preservation and organ procurement services, has announced…